Hematopoietic stem cell transplantation for the management of follicular lymphoma

about

Hematopoietic stem cell transplantation for the management of follicular lymphoma

Item

http://www.wikidata.org/entity/Q37194061

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 03 May 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Hematopoietic stem cell transplantation for the management of follicular lymphoma

@en

Hematopoietic stem cell transplantation for the management of follicular lymphoma.

@nl

type

Item

label

Hematopoietic stem cell transplantation for the management of follicular lymphoma

@en

Hematopoietic stem cell transplantation for the management of follicular lymphoma.

@nl

prefLabel

Hematopoietic stem cell transplantation for the management of follicular lymphoma

@en

Hematopoietic stem cell transplantation for the management of follicular lymphoma.

@nl

P1476

Hematopoietic stem cell transplantation for the management of follicular lymphoma

@en

P2093

Chitra Hosing

http://www.w3.org/2001/XMLSchema#string

P2860

Rituximab as maintenance therapy for patients with follicular lymphoma

New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project

Follicular lymphoma: have we made any progress?

Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma.

An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation.

New treatment options have changed the survival of patients with follicular lymphoma.

Phase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma.

Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial response.

Cytokine dysregulation and acute graft-versus-host disease.

P304

69-80

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/SCCAA.S7014

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24198512

http://www.w3.org/2001/XMLSchema#string

P932

3781727

http://www.w3.org/2001/XMLSchema#string